$46.00 exc. GST
Recommended Retail Price
The Integra Nutritionals® nutrigenomic approach is much less reliant on traditional disease-based markers and much more focused on nutrient-based and metabolic markers. For this reason, the tests selected here provide valuable information to assist the clinician in monitoring the status of relevant key markers.
The tests are convenient for both the clinician and the patient who may self-collect the sample if the consultation is not face-to-face. With their rapid turnaround time from sampling to results, the blood spot tests are an ideal
way for a clinician to measure a patient’s response to treatment.
What are the benefits?
We have chosen tests which give very good representation of your patient’s diet and lifestyle over a period of
time and are ideal to test before, during and following treatment.
• Enhanced patient monitoring
• Ability to incorporate test reviews into appointment schedule
• Better patient compliance
• Enable individualised treatment
Homocysteine (Hcy) is a marker of oxidative stress, best known for its predictability of cardiovascular disease. As Hcy is a precursor to glutathione synthesis, impairment in these pathways reveals its clear association with redox imbalance.
Optimising Homocysteine levels may not be as simple as addressing methylation pathways unless the therapeutic intervention also addresses Nrf2 activation, needed to activate several of the glutathione-synthesising genes.
To manage homocysteine levels, ensure that Nrf2 activity is addressed with therapeutics such as sulforaphane.
Homocysteine is seen as an important predictor of cardiovascular health.
